Medicines in 2019

Summary

Both the sales of pharmaceuticals and reimbursements for medicine costs continued increasing in 2019. The sales of prescription medicines used in the outpatient setting grew faster than the sales of over-the-counter medicines, but the clearly strongest growth was seen in the sales of medicines 
to hospitals and other institutions at wholesale prices. For the first time, the reimbursements paid for medicine costs exceeded EUR 1.5 billion. The amount of additional refunds paid to clients due to large medicine costs increased by nearly one fifth from the preceding year.

Full text (julkari.fi)

Authors

Leena Saastamoinen, Katri Aaltonen, Tinna Voipio

Additional Information

• Peer-Reviewed: no.
• Open Access: yes.
• Cite as: Saastamoinen, L., Aaltonen, K., & Voipio, T. (2020). Lääkevuosi 2019. Teoksessa Suomen lääketilasto 2019 / Finnish statistics on medicines 2019. Lääkealan turvallisuus- ja kehittämiskeskus Fimea & Kansaneläkelaitos. https://urn.fi/URN:NBN:fi-fe20201217101079